| Dr Ivonne Ivette Felix, MD | |
|
971 Hunt Club Blvd, Auburn Hills, MI 48326-3686 | |
| (248) 299-4345 | |
| (248) 299-1288 |
| Full Name | Dr Ivonne Ivette Felix |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 971 Hunt Club Blvd, Auburn Hills, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063492882 | NPI | - | NPPES |
| 4676135 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 4301062904 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ivonne Ivette Felix, MD 971 Hunt Club Blvd, Auburn Hills, MI 48326-3686 Ph: (248) 299-4345 | Dr Ivonne Ivette Felix, MD 971 Hunt Club Blvd, Auburn Hills, MI 48326-3686 Ph: (248) 299-4345 |
News Archive
Geospiza, Inc. the market leading developer of the GeneSifter® software platform for genetic analysis, today announced that the National Human Genome Research Institute of the National Institutes of Health has awarded the company a phase II SBIR grant to collaborate with researchers at Weil Cornell Medical College, Mayo Clinic to develop a new application that quickly identifies and visualizes DNA sequence variations found when comparing normal and cancer tissues using Geospiza's GeneSifter cloud computing platform.
A new study led by Bisola O. Ojikutu of Brigham and Women's Hospital in Boston suggests not only do these communities have a higher infection, but they are also experiencing lower vaccine distribution. The team suggests that reformation for equitable vaccine delivery is necessary to eliminate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test kit that can predict treatment and survival outcomes in kidney cancer patients. This breakthrough was recently reported in European Urology, the world's top urology journal.
In a counterintuitive result, researchers found that giving male rats a low dose of the endotoxin lipopolysaccharide (LPS) prior to inducing a model of acute kidney injury (AKI) improved outcomes.
Significant headway has been made in controlling malaria. However, two vexing problems remain: currently available treatments are unable to block transmission of the parasite that causes the disease, and the parasite often becomes resistant to drugs.
› Verified 8 days ago